# Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

> **NCT00005971** · PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 17 (actual)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **DRUG:** alvocidib

## Key facts

- **NCT ID:** NCT00005971
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07-04
- **Primary completion:** 2001-08-24
- **Final completion:** 2009-12-21
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005971, "Flavopiridol in Treating Patients With Metastatic Malignant Melanoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00005971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*